Skip to main content
Retour
Watch Compare

Benitec Biopharma Inc.

Qualité des données : 83%
BNTC
NASDAQ Manufacturing Chemicals
11,42 €
▲ 0,41 € (3,72%)
Cap. Boursière: 377,15 M
Prix
11,01 €
Cap. Boursière
377,15 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -26,16 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-38,20%
Au-dessus de la moyenne du secteur (-53,58%)
ROIC-33,16%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio67,69
Interest CoverageN/A

Valorisation

PE (TTM)
-7,03
En dessous de la moyenne du secteur (-1,48)
P/B Ratio2,01
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -7,0 -1,5
P/B 2,0 1,6
ROE % -38,2 -53,6
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

6 analystes
Buy
Actuel
11,42 €
+111.6%
Objectif
24,17 €
17,00 €
24,00 €
32,00 €
Prévisions
BPA Prévisionnel -1,13 €
CA Est. 18,22 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -1,13 €
-1,59 € – 0,20 €
 18,22 M 6
FY2026 -1,13 €
-1,49 € – -0,97 €
 0,0 6

Surprises de Résultats

Derniers 6 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,23 € -0,26 € -15,0%
Q32025 -0,36 € -0,22 € +38,2%
Q22025 -0,31 € -0,42 € -34,3%
2026-Q2 -0,29 € -0,26 € +11,0%
2026-Q1 -0,28 € -0,22 € +20,3%
Q12025 -0,35 € -0,24 € +31,1%

ETFs Holding This Stock

PINK logo PINK Simplify Health Care ETF
0,62% weight
IRSSX IRSSX
0,01% weight
VVICX VVICX
0,01% weight
IRSIX IRSIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight

Dividend History

Ex-Date Payment Date Amount Yield
Jun 01, 2018 — 0,77 € N/A

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -53,66 M
ROE -38,20% ROA -37,43%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26,16 M
ROIC -33,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 67,69
Interest Coverage N/A Asset Turnover N/A
Working Capital 186,79 M Tangible Book Value 187,36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7,03 Forward P/E N/A
P/B Ratio 2,01 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6,94%
Market Cap 377,15 M Enterprise Value 188,36 M
Per Share
EPS (Diluted TTM) -1,05 Revenue / Share N/A
FCF / Share -0,76 OCF / Share -0,76
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 48,75%
SBC-Adj. FCF -42,69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 59 000,0
Net Income -37,92 M -21,75 M -19,56 M -18,21 M -13,88 M
EPS (Diluted) -1,05 -5,51 -14,12 -2,23 —
Gross Profit — — — — —
Operating Income -41,77 M -22,49 M -19,08 M -17,85 M -13,60 M
EBITDA — — — — —
R&D Expenses 18,33 M 15,61 M 12,77 M 11,27 M 7,02 M
SG&A Expenses — — — — —
D&A 66 000,0 87 000,0 136 000,0 167 000,0 231 000,0
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 99,59 M 52,21 M 4,46 M 5,97 M 21,38 M
Total Liabilities 2,30 M 4,96 M 4,26 M 3,09 M 1,37 M
Shareholders' Equity 97,30 M 47,25 M 202 000,0 2,88 M 20,01 M
Total Debt — — — — —
Cash & Equivalents 97,74 M 50,87 M 2,48 M 4,06 M 19,77 M
Current Assets 98,52 M 51,67 M 3,73 M 4,82 M 20,61 M
Current Liabilities 1,80 M 4,92 M 3,98 M 2,53 M 1,37 M